When to Stop Antibiotics in the Critically Ill?

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Pharmacology

Background:

• Antibiotic use has significantly increased in critically ill patients over the last century.
• Concerns are rising regarding appropriate antibiotic treatment guidelines and durations.
• Antibiotic administration carries short-term (hepatic/renal dysfunction), intermediate (superinfections), and long-term (antimicrobial resistance) risks, exacerbated by prolonged or broad-spectrum use.

Purpose of the Study:

• To review strategies for determining appropriate antimicrobial therapy duration.
• To highlight the clinical shift towards multi-modal approaches for optimizing antibiotic cessation.
• To propose an integrated approach for informed clinical decision-making in antibiotic treatment.

Main Methods:

• Literature review focusing on strategies for antimicrobial therapy duration.
• Analysis of the clinical trend towards multi-modal decision-making for antibiotic courses.
• Conceptualization of an approach integrating biomarker assays and interdisciplinary teams.

Main Results:

• Increasing focus on strategies to determine optimal antimicrobial therapy duration.
• Emerging clinical trend towards multi-modal strategies for antibiotic cessation.
• Identification of biomarker assays and interdisciplinary collaboration as key components for future decision-making.

Conclusions:

• Optimizing antibiotic duration is essential to mitigate treatment risks and combat antimicrobial resistance (AMR).
• A multi-modal approach, combining biomarker data with interdisciplinary team input (pharmacists, nurses, physicians, microbiologists), represents a promising strategy for evidence-based clinical decision-making in antibiotic therapy.